Episode Details
Back to Episodes
From FDA PMA to Health Canada: A Guide to Licensing High-Risk Medical Devices
Published 1 year, 2 months ago
Description
Holding FDA PMA approval is a significant achievement, but what does it mean for entering the Canadian market? This episode breaks down the essential steps and requirements for obtaining a Health Canada Medical Device Licence for your high-risk device. We explore how to leverage your existing FDA data while navigating Canada's unique regulatory landscape.
• Does FDA PMA guarantee a Health Canada licence?
• What are the Canadian device classifications for high-risk products?
• Is an FDA-compliant QMS enough for Health Canada?
• What is the Medical Device Single Audit Program (MDSAP) and why is it critical?
• What is the difference between a Medical Device Licence (MDL) and a Medical Device Establishment Licence (MDEL)?
• Can my FDA submission documents be used for a Health Canada application?
• What specific formatting does Health Canada require for submissions?
• Are there unique labelling requirements for the Canadian market?
• How have regulations changed since the 2016 notice on using FDA guidance?
Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.